Clinical Trial Update: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating genetic analysis-guided dosing of irinotecan within mFOLFIRINOX for locally advanced gastroesophageal and stomach cancers has been susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma

Drugs mentioned

• Irinotecan hydrochloride (Camptosar) (Irinotecan)

Snippet

Sponsor: University of Chicago | Conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma | Phase 4 | Status: SUSPENDED